Explore Our Core Services
.png?width=130&height=130&name=icon%20(3).png){kind=icon}
regulatory sciences
.png?width=130&height=130&name=icon%20(1).png){kind=icon}
clinical research solutions
.png?width=130&height=130&name=icon%20(2).png){kind=icon}
quality & compliance
.png?width=130&height=130&name=icon%20(4).png){kind=icon}
pharmacovigilance solutions
.png?width=130&height=130&name=icon%20(5).png){kind=icon}
medical information
fsp solutions
As an extension of your internal team, we bring our top-tier professionals, proven processes and oversight to your functional area or company programs. Our flexible FSP solutions are purpose-built to drive efficiency, accelerate timelines, and deliver specialized expertise across every stage of clinical development.
.png?width=130&height=130&name=icon%20(6).png){kind=icon}
digital transformation
Empowering our partners to turn scientific breakthroughs into life-changing therapies
Our team of experts have decades of experience across a wide variety of therapeutic areas & specialties. We work as an extension of your team, bringing you immediate resources who will align with your needs and processes.
-2.png?width=300&height=300&name=Untitled%20design%20(10)-2.png)
News & Insights
July 28, 2025
Understanding PADER: A Key Pharmacovigilance Requirement for the U.S. Market
Learn about PADER, a crucial pharmacovigilance requirement for U.S. drug safety monitoring, and how it differs from PSUR in ensuring compliance and patient safety. Summarizing the main point of the...
July 25, 2025
Understanding the Roles of LPPV, QPPV, and the PSMF in Pharmacovigilance: A Guid...
Learn about the crucial roles of QPPV, LPPV, and PSMF in ensuring effective pharmacovigilance and regulatory compliance for Marketing Authorization Holders (MAHs).
July 24, 2025
FDA Publishes over 200 Complete Response Letters (CRLs)
FDA's new transparency with over 200 CRLs empowers sponsors to navigate regulatory challenges more effectively, accelerating drug approvals and enhancing patient access to treatments.
.png?width=320&height=185&name=Obesity%20%E2%80%93%20Accelerated%20Timelines%20(1).png)
.png?width=320&height=185&name=labeling-webinar-thumbnail%20(1).png)
News & Insights
July 8, 2025
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...
ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...
January 31, 2025
ProPharma Recognized for AI Excellence at ECCCSA
ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.
October 21, 2024
ProPharma Appoints Brian Tuttle as Chief Financial Officer
ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.
